Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lot-to-Lot Consistency, Bridging, and Safety Trial of ChimeriVax -Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines.

Next Previous
Trial Profile

Lot-to-Lot Consistency, Bridging, and Safety Trial of ChimeriVax -Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 09 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Japanese encephalitis vaccine (Primary) ; Hepatitis A vaccine inactivated
  • Indications Hepatitis A; Japanese encephalitis
  • Focus Pharmacodynamics; Registrational
  • Sponsors Sanofi; Sanofi Pasteur

Most Recent Events

  • 14 Aug 2014 According to ClinicalTrials.gov record, additional secondary endpoints added.
  • 28 Oct 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
  • 28 Oct 2009 Actual patient number (1199) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top